Retension Pharmaceuticals, Inc. (RTSN)

Retension Pharmaceuticals will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Retension Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-12.56	-6.88	-2.28
Net Income	-11.94	-6.3	-1.91

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	13.49	18.9	8.19
Total Debt	-	0	0.01
Net Cash (Debt)	13.49	18.9	8.18
Net Cash Growth	-	131.11%	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-11.89	-7.78	-1.76
Free Cash Flow	-11.89	-7.78	-1.76
Free Cash Flow Growth	-	-	-